Catalent Completes $5.5 Million Expansion of Clinical Storage at Philadelphia Facility

Thursday, April 12, 2018 Clinical Trials News
Email Print This Page Comment bookmark
Font : A-A+

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it has completed a $5.5 million expansion program at its 200,000+ square foot Philadelphia, Pennsylvania, site to provide additional clinical packaging and storage capacity.

SOMERSET, N.J., April 12, 2018 /PRNewswire-PRWeb/ -- Catalent Pharma Solutions, the leading global provider of advanced

delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it has completed a $5.5 million expansion program at its 200,000+ square foot Philadelphia, Pennsylvania, site to provide additional clinical packaging and storage capacity.

The facility, which is located near many customers and major transportation hubs, is also one of the largest sites in Catalent's global clinical supply network. The investment has provided the site with a 40 percent increase in pallet space for both refrigerated and ambient clinical storage, additional cold chain packaging areas, and a new clinical label control area. The building also features a new campus-wide environmental monitoring and building management system.

"The expansion not only allows us to meet the demand for additional capacity to serve large-scale clinical studies today, but also provides the space necessary for future growth," said Albert Quintero, General Manager, Clinical Supply Services. He added, "We look forward to welcoming new and existing customers at these new facilities."

With sites in the U.S., U.K., Germany, Japan and China, and an extended network of over 50 depots, Catalent's clinical supply services team has the capability and expertise to handle a broad range of international compliance and distribution requirements, and so help to expedite clinical trials by ensuring customers are reliably supplied where and when needed around the globe.

For further information on Catalent's Clinical Supply Services business visit catalent.com/clinical.

About Catalent Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 11,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2017 generated over $2 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

 

SOURCE Catalent Pharma Solutions



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store